本报（chinatimes.net.cn）记者夏高琴 南京报道 对此，靖江市委宣传部相关工作人员向《华夏时报》记者表示："已关注到万林物流业绩说明会上相关 内容，靖江一直以来对万林物流在产业规划、配套设施、行政审批、金融服务等方面提供全方位和全周 期的服务，不存在推诿情况，金融机构也不存在不提供服务情况。"对于银行授信受限事项，该工作人 员向本报记者表示："对于万林公司面临的问题，我们绝对不会置之不理。我们当地金融办也一直在密 切关注相关情况，并积极协调银行机构和他们交流。" "摘帽"未能恢复银行授信，贸易代理业务停摆 万林物流银行授信被停已超3年之久。 《华夏时报》记者翻阅万林物流以往公告注意到，2022年年报该公司首次在定期报告中提及"受公司在 上海证券交易所被特殊标记影响，公司银行授信已基本暂停，依托于银行授信的贸易代理业务严重受 限。公司贸易代理业务的发展存在不确定性，面临全面停止的风险"。据了解，2022年5月5日万林物流 因2021年年报被出具非标意见，公司股票交易被实施其他风险警示，直到2024年7月30日万林物流正式 撤销风险警示。 然而2024年年报，以及2025年半年报关于银行授信仍是"公 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002425 证券简称：ST凯文 公告编号：2025-056 凯撒（中国）文化股份有限公司 第八届董事会第十八次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记载、误导性陈述或者重大遗 漏。 凯撒（中国）文化股份有限公司（以下简称"公司"、"凯撒文化"）第八届董事会第十八次会议于2025年 9月26日以现场结合通讯表决的方式召开。会议通知于2025年9月25日以电子邮件送达全体董事和高级管 理人员。本次会议由董事长郑雅珊女士召集，会议应出席的董事9人, 实际出席董事9人。本次会议的召 集和召开符合《公司法》和《公司章程》的有关规定，合法有效。会议经过讨论，作出如下决议： 一、会议以9票同意、0票弃权、0票反对的表决结果，审议通过《关于向银行申请授信提供资产抵押的 议案》。 具体内容详见同日披露于《证券时报》《中国证券报》《上海证券报》《证券日报》和巨潮资讯网 （http://www.cninfo.com.cn）的公告。 特此公告。 凯撒（中国）文化股份有限公司董事会 2025年9月26日 股票代码：002425 证券简称 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 证券代码：002480 证券简称：新筑股份 公告编号：2025-090 一、召开会议的基本情况 成都市新筑路桥机械股份有限公司 关于召开2025年 第八次临时股东大会的通知公告 （一）股东大会届次：2025年第八次临时股东大会。 （二）股东大会召集人：成都市新筑路桥机械股份有限公司（以下简称"公司"）董事会。 公司第八届董事会第三十四次会议已审议通过《关于提请召开2025年第八次临时股东大会的议案》。 （三）会议召开的合法、合规性 本次股东大会会议的召开符合有关法律、行政法规、部门规章、规范性文件和公司章程的相关规定。 （四）会议召开日期、时间 1、现场会议时间：2025年10月15日（星期三）下午15：00。 2、网络投票的日期和时间为：2025年10月15日，其中，通过深圳证券交易所交易系统进行网络投票的 具体时间为2025年10月15日9:15-9:25，9:30-11:30和13:00-15:00；通过深圳证券交易所互联网投票系统 进行网络投票的具体时间为 ...

Group 1 - The company, Qicai Chemical, has approved a proposal to apply for comprehensive credit facilities from banks, amounting to a total of up to 6 billion yuan [1] - The company plans to apply for a credit facility of no more than 500 million yuan from Industrial Bank and no more than 100 million yuan from Postal Savings Bank [1] - The actual controllers of the company, Xu Huixiang and Zang Jie, will provide unconditional joint liability guarantees, amounting to no more than 192 million yuan and corresponding amounts, with the company exempt from guarantee fees [1] Group 2 - The credit facility amount does not equal the actual financing amount, which is subject to bank approval [1] - This transaction constitutes a related party transaction and does not fall under major asset restructuring, pending approval from the shareholders' meeting [1] - From the beginning of 2025 to the disclosure date, the actual controllers have provided multiple bank credit guarantees for the company, totaling 730 million yuan in credit and 809.32 million yuan in guarantees, with actual occurrences of 465 million yuan [1]

Core Viewpoint - The company has approved a comprehensive credit limit of up to RMB 745.3 million and USD 9 million for 2025, with a total guarantee amount not exceeding RMB 245.9 million for its subsidiaries [1][16]. Summary by Sections Guarantee Overview - The company and its subsidiaries will apply for a comprehensive credit limit of RMB 745.3 million and USD 9 million for 2025, equivalent to RMB 751.77 million [1]. - The total guarantee amount for subsidiaries is capped at RMB 245.9 million, with RMB 64.9 million allocated for subsidiaries with an asset-liability ratio exceeding 70% and RMB 181 million for those below this threshold [1]. Guarantee Progress - Recently, the company signed maximum guarantee contracts with banks for its subsidiaries, with the maximum debt amounts being RMB 1 million, RMB 3 million, and RMB 6 million for different subsidiaries [2][12]. Main Content of Guarantee Contracts - The guarantee period for each financing is calculated from the debt maturity date, lasting three years [4][6]. - The guarantee covers all debts arising from the main contract, including principal, interest, penalties, and costs incurred by the creditor [10][14]. Cumulative Guarantee Amount and Overdue Guarantees - As of the announcement date, the total guarantee amount provided by the company and its subsidiaries is RMB 245.9 million, with a total outstanding guarantee balance of RMB 55.28 million, representing 20.06% of the company's latest audited net assets [16]. - There are no overdue guarantees or guarantees involved in litigation [16]. Documents for Reference - The company has signed several guarantee contracts with banks, which are available for review [17].

Core Points - Tianchen Medical (688013) stock price increased by 17.76% to 67.25 CNY as of September 12, 2025, reaching a nearly one-year high of 68.0 CNY during the week [1] - The company's total market capitalization is 5.484 billion CNY, ranking 66th out of 126 in the medical device sector and 3074th out of 5153 in the A-share market [1] Company Announcements - Tianchen Medical will participate in the 2025 semi-annual performance briefing for the medical device industry on September 17, 2025, with key executives present for investor interaction [1][4] - The company approved a proposal to use up to 200 million CNY of temporarily idle raised funds for cash management, with a usage period of 12 months [2][4] - The company and its subsidiaries plan to apply for a total credit limit of up to 300 million CNY from banks within 12 months [2][4] - The company’s shareholders meeting approved the 2025 annual audit firm reappointment and the 2025 semi-annual profit distribution plan, with over 99.98% approval from ordinary shareholders [2][4]

Group 1 - The company will not distribute profits or increase capital from reserves during the reporting period [1] - The board of directors guarantees the authenticity, accuracy, and completeness of the semi-annual report [1][3] - The semi-annual report has not been audited [1] Group 2 - The company has modified its articles of association following the cancellation of 11,432,300 shares, reducing total share capital from 1,428,770,000 shares to 1,417,337,700 shares [3] - The modification of the articles of association requires approval from the shareholders' meeting [3] Group 3 - The company plans to provide guarantees for its subsidiaries, including a guarantee of 80 million RMB for Tengzhou Jinjing Glass Co., Ltd. and 18 million MYR for Jinjing Technology Malaysia Sdn. Bhd. [5][10] - The total external guarantee amount is 832.49 million RMB, accounting for 14.68% of the company's latest audited net assets [13] Group 4 - The company has applied for an increase in bank credit limits for its subsidiaries to support normal production and operation needs [16] - The board of directors has approved the application for the credit limit increase [16] Group 5 - The company will hold its first extraordinary shareholders' meeting on September 11, 2025, to discuss various matters including the modification of the articles of association [20][24] - The meeting will utilize both on-site and online voting methods [20][22] Group 6 - The company will hold a semi-annual performance briefing on September 2, 2025, to discuss the operating results and financial status for the first half of 2025 [44][46] - Investors can submit questions in advance for the briefing [46][48]

Group 1 - The company, Shandong Jinjing Technology Co., Ltd., has approved an increase in bank credit limits for its subsidiaries to support normal production and operational needs [1][2] - The subsidiaries applying for the credit increase are Tengzhou Jinjing Glass Co., Ltd. and Jinjing Technology Malaysia SDN.BHD., with proposed new credit limits of 80 million yuan and 30.41 million yuan (equivalent to 18 million ringgit) respectively [1][2] - The board of directors has confirmed that the necessity for the credit increase is sufficient and the intended use of the funds is legal and compliant [2]

Core Viewpoint - The company, Kailaiying, is seeking to apply for a comprehensive credit facility of up to 2.5 billion RMB to ensure the continuity of its banking credit lines and support its operational and developmental funding needs [1] Group 1: Credit Facility Application - The company plans to apply for a credit facility from several financial institutions, including Shanghai Pudong Development Bank, China Merchants Bank, Bank of China, Industrial and Commercial Bank of China, Citibank (China), Standard Chartered Bank, and Bohai Bank [1] - The proposed credit facility is aimed at meeting the daily operational funding and business development needs of the company and its subsidiaries [1] - The credit facility will have a term of no more than one year, subject to approval by the company's board of directors [1]

Core Viewpoint - The board of directors of Dongguan Kaige Precision Machinery Co., Ltd. has approved the 2025 semi-annual report and related documents, confirming their compliance with legal and regulatory requirements, and asserting the accuracy and completeness of the information presented [1][2]. Group 1: Board Meeting Resolutions - The board meeting held on August 21, 2025, was legally convened with all five directors present, and the resolutions passed were deemed valid [1]. - The 2025 semi-annual report and its summary were approved, reflecting the company's actual situation without any false statements or omissions [1][2]. - The special report on the use of raised funds for the first half of 2025 was also approved, confirming compliance with relevant regulations and the absence of any misuse of funds [2]. Group 2: Financial Management Decisions - The board approved the use of up to RMB 400 million of idle raised funds for cash management, allowing investment in high-security and liquid financial products, with a validity period of 12 months [3]. - The board's decision to recognize asset impairment provisions was based on sufficient evidence and compliance with accounting standards, accurately reflecting the company's financial status [3]. - The board approved the use of self-owned assets as collateral for bank credit applications to meet operational funding needs, ensuring no significant financial risk to the company [4]. Group 3: Upcoming Shareholder Meeting - The board has scheduled the first extraordinary general meeting of 2025 for September 9, 2025, to discuss the collateralization proposal, combining on-site and online voting methods [5].